Archives
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-10-02
The 2026 MedComm study identifies NAT1 as a metabolic and immune regulator that links ENO1 acetylation and lactate production to TRAF6-dependent stabilization of PD-L1 in colorectal cancer. Its combination of multi-omics analysis, mechanistic cell studies, patient data, and mouse immunotherapy models provides a framework for testing how glycolytic flux contributes to checkpoint resistance.
-
Neticonazole Hydrochloride: Assay Guide
2026-10-01
This scenario-based guide explains how Neticonazole Hydrochloride (SKU C8715) can be incorporated into fungal susceptibility, cell viability, proliferation, cytotoxicity, exosome, and apoptosis studies. It emphasizes formulation control, assay compatibility, interpretation limits, and practical vendor-selection criteria for biomedical laboratories.
-
Quantifying Fractional Killing by High-Throughput Microscopy
2026-10-01
Inde, Rodencal, and Dixon present a high-throughput imaging protocol for measuring drug-induced fractional killing as a time-dependent population phenotype rather than relying only on endpoint viability. The workflow combines fluorescent live-cell labeling, dead-cell detection, automated microscopy, and parallel condition testing to reveal variability in killing responses to mitogen-activated protein kinase pathway inhibitors.
-
NSC-23766: A Rac1 Assay Design Framework
2026-09-30
NSC-23766 is a Rac GTPase inhibitor that enables precise interrogation of Rac1 activation across cancer, endothelial, and metabolic assays. This guide explains how to use its mechanism alongside the newly defined lactate-GPR81-FARP1-GLUT4 axis without overstating pathway selectivity.
-
α-Linolenic Acid: Applied Research Workflows
2026-09-30
Build reproducible ALA experiments for lipid flux, cardiovascular signaling, inflammation, and cancer models with controlled dosing and handling. The workflow also shows how to use the recent arachidonic acid immunity study as a disciplined comparator—not as evidence that ALA is already a vaccine adjuvant.
-
IGF2BP3, m6A, and Ferroptosis in Glioma
2026-09-29
This Cell Death and Disease study identifies IGF2BP3 as an m6A-dependent regulator of GPX4 expression and ferroptosis in glioma. Its experiments connect RNA modification, transcript stability, tumor formation, and microglial phagocytosis, providing a mechanistic framework for studying post-transcriptional control of glioma survival.
-
Neticonazole Hydrochloride Research Workflows
2026-09-29
Neticonazole Hydrochloride supports two distinct experimental tracks: fungal susceptibility and exploratory colorectal cancer research. This guide connects practical assay design, formulation considerations, exosome and apoptosis readouts, and troubleshooting without treating preclinical oncology findings as established clinical use.
-
GW4064: A Causal Probe of FXR in Cholestasis
2026-09-28
GW4064 is a selective non-steroidal FXR agonist for dissecting bile acid efflux, lipid regulation, and cholestatic injury. This article presents an assay-centered framework linking FXR activation to BSEP, MRP2, tight-junction integrity, and interpretation of toxicology findings.
-
SN-38 Disrupts FUBP1–FUSE Binding: Study Insights
2026-09-28
A 2017 study found that camptothecin and SN-38 can inhibit the binding of the oncogenic transcriptional regulator FUBP1 to its DNA target FUSE in vitro, with associated changes in FUBP1-regulated gene expression in hepatocellular carcinoma cells. The findings suggest a potential additional mechanism alongside topoisomerase I inhibition, while leaving its contribution to cellular and clinical responses unresolved.
-
Staurosporine: Practical Workflows for Cancer Research
2026-09-27
Use Staurosporine to establish apoptosis benchmarks and interrogate kinase-dependent signaling—while keeping its broad activity distinct from a selective mechanistic probe. A practical dose-and-time workflow, paired with matrix-aware assay design, helps make cancer-cell results more interpretable.
-
AMPK restrains autophagy during energy stress
2026-09-26
Park, Lee, and Kim challenge the prevailing view that AMPK generally activates autophagy during glucose shortage. Their findings show that AMPK can suppress ULK1 signaling during energy stress while helping preserve autophagy machinery, separating immediate pathway activity from the cell’s capacity to recover later.
-
Propranolol for Essential Tremor Research
2026-09-25
Use Propranolol to probe β-adrenergic blockade across peripheral and central tremor-related workflows, while keeping mechanistic claims tied to measured outcomes. A 2024 TMS study offers a practical translational framework: pair tremor assessment with corticospinal excitability and short afferent inhibition rather than relying on tremor scores alone.
-
Sulfo-Cy5 carboxylic acid for nanoparticle assays
2026-09-25
Use this water-compatible far-red dye to build fluorescence readouts for nanoparticle-associated cargo, labeled biomolecules, and tissue imaging—while distinguishing cargo release from particle movement. The workflow explains when the non-activated carboxylic acid is appropriate, when an NHS ester is a better choice, and how to validate signal before interpreting biological targeting.
-
S Tag Peptide: Practical Fusion Tag Workflow
2026-09-24
S Tag Peptide supports recombinant protein detection and can be incorporated into fusion-tag workflows where protein solubility improvement or antibody-based detection is needed. The supplied peptide is water- and DMSO-soluble but ethanol-insoluble; use a genetically encoded S-peptide fusion tag for recombinant expression, and do not assume the free peptide alone provides a complete purification or expression solution.
-
Neticonazole Hydrochloride in Cell Assay Workflows
2026-09-24
This scenario-led guide explains how to evaluate Neticonazole Hydrochloride (SKU C8715) in viability, proliferation, cytotoxicity, antifungal, and exploratory colorectal cancer research. It separates documented product properties from workflow suggestions and highlights assay controls, solubility, storage, and evidence limitations.